Jane Street’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-177,008
Closed -$434K 12987
2025
Q4
$434K Buy
177,008
+131,478
+289% +$571K ﹤0.01% 8022
2025
Q3
$306K Buy
45,530
+7,141
+19% +$46.6K ﹤0.01% 8864
2025
Q2
$226K Sell
38,389
-7,706
-17% -$50.2K ﹤0.01% 8349
2025
Q1
$387K Sell
46,095
-84,300
-65% -$758K ﹤0.01% 7351
2024
Q4
$970K Sell
130,395
-54,545
-29% -$365K ﹤0.01% 5456
2024
Q3
$1.07M Buy
184,940
+103,686
+128% +$666K ﹤0.01% 5750
2024
Q2
$540K Buy
81,254
+50,181
+161% +$405K ﹤0.01% 6896
2024
Q1
$406K Buy
31,073
+10,821
+53% +$144K ﹤0.01% 7063
2023
Q4
$258K Buy
+20,252
New +$205K ﹤0.01% 7851
2023
Q3
Sell
-37,435
Closed -$958K 9387
2023
Q2
$958K Sell
37,435
-14,548
-28% -$375K ﹤0.01% 5250
2023
Q1
$1.31M Buy
+51,983
New +$1.22M ﹤0.01% 4522
2022
Q4
Sell
-39,936
Closed -$920K 10152
2022
Q3
$881K Buy
+39,936
New +$773K ﹤0.01% 5641

Other funds holding TMCI

Jane Street's TMCI Position: Q1 2026 in Review

Jane Street sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 177,008 shares — an estimated $434K sold.

Jane Street first reported a position in TMCI in Q3 2022 and held it in 12 quarters. The position peaked at $1.31M in Q1 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Jane Street reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 177,008 Treace Medical Concepts shares in Q1 2026, an estimated $434K.
  • Jane Street first reported a position in Treace Medical Concepts in Q3 2022 and held it in 12 quarters.
  • Jane Street's Treace Medical Concepts position peaked at $1.31M in Q1 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.